CLK2 inhibition changes the expression and alternative splicing of EMT-associated genes in breast cancer27, and the activation of the splice factor SPF45 following its phosphorylation by CLK1 promotes cancer cell line migration and invasion of ovarian cancer cells40. The gene discussed is RBM17; the disease is cancer.